Related Experiment Video
Updated: Aug 7, 2026
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Tissue microarray technology for high-throughput molecular profiling of cancer
O P Kallioniemi1, U Wagner, J Kononen
1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Room 4A24, MSC 4465, Bethesda, MD 20892, USA. okalli@nhgri.nih.gov
Abstract:
Tissue microarray (TMA) technology allows rapid visualization of molecular targets in thousands of tissue specimens at a time, either at the DNA, RNA or protein level. The technique facilitates rapid translation of molecular discoveries to clinical applications. By revealing the cellular localization, prevalence and clinical significance of candidate genes, TMAs are ideally suitable for genomics-based diagnostic and drug target discovery. TMAs have a number of advantages compared with conventional techniques. The speed of molecular analyses is increased by more than 100-fold, precious tissues are not destroyed and a very large number of molecular targets can be analyzed from consecutive TMA sections. The ability to study archival tissue specimens is an important advantage as such specimens are usually not applicable in other high-throughput genomic and proteomic surveys. Construction and analysis of TMAs can be automated, increasing the throughput even further. Most of the applications of the TMA technology have come from the field of cancer research. Examples include analysis of the frequency of molecular alterations in large tumor materials, exploration of tumor progression, identification of predictive or prognostic factors and validation of newly discovered genes as diagnostic and therapeutic targets.
Insights
Tissue microarray (TMA) technology enables rapid, high-throughput analysis of molecular targets in thousands of tissue specimens. This accelerates genomics-based diagnostics and drug discovery, particularly in cancer research.
Area of Science:
- Biotechnology
- Genomics
- Molecular Pathology
Background:
- Tissue microarray (TMA) technology offers a powerful method for analyzing molecular targets across numerous tissue samples simultaneously.
- It enables simultaneous assessment at DNA, RNA, or protein levels, bridging molecular discoveries with clinical applications.
Purpose of the Study:
- To highlight the advantages and applications of TMA technology in research and diagnostics.
- To emphasize its role in genomics-based discovery and drug target identification.
Main Methods:
- Utilizes TMA technology for high-throughput analysis of molecular targets (DNA, RNA, protein) in thousands of tissue specimens.
- Leverages automation for increased throughput and analysis of archival tissues.
Main Results:
- TMAs significantly increase the speed of molecular analyses (over 100-fold) compared to conventional methods.
- Preserves precious tissues and allows analysis of a vast number of targets from consecutive sections.
- Facilitates the study of archival specimens, expanding their utility in genomic and proteomic surveys.
Conclusions:
- TMA technology is ideal for genomics-based diagnostics and drug target discovery due to its efficiency and ability to analyze large cohorts.
- Its applications are prominent in cancer research, aiding in the analysis of molecular alterations, tumor progression, and validation of new therapeutic targets.
